Witnessing the stock’s movement on the chart, on Wednesday, CytomX Therapeutics Inc (NASDAQ: CTMX) had a quiet start as it plunged -3.29% to $4.11, before settling in for the price of $4.25 at the close. Taking a more long-term approach, CTMX posted a 52-week range of $0.40-$4.62.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -108.84%. This publicly-traded company’s shares outstanding now amounts to $165.07 million, simultaneously with a float of $127.86 million. The organization now has a market capitalization sitting at $696.38 million. At the time of writing, stock’s 50-day Moving Average stood at $3.78, while the 200-day Moving Average is $2.31.
CytomX Therapeutics Inc (CTMX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. CytomX Therapeutics Inc’s current insider ownership accounts for 24.54%, in contrast to 65.29% institutional ownership. According to the most recent insider trade that took place on Nov 06 ’25, this organization’s CEO sold 101,793 shares at the rate of 4.54, making the entire transaction reach 461,906 in total value, affecting insider ownership by 987,891.
CytomX Therapeutics Inc (NASDAQ: CTMX) Trading Performance Indicators
Let’s observe the current performance indicators for CytomX Therapeutics Inc (CTMX). It’s Quick Ratio in the last reported quarter now stands at 3.64. Alongside those numbers, its PE Ratio stands at $9.83, and its Beta score is 2.42. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.13.
In the same vein, CTMX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.42, a figure that is expected to reach -0.09 in the next quarter, and analysts are predicting that it will be -0.38 at the market close of one year from today.
Technical Analysis of CytomX Therapeutics Inc (CTMX)
Going through the that latest performance of [CytomX Therapeutics Inc, CTMX]. Its last 5-days volume of 2.56 million was inferior to the volume of 3.28 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 78.75% While, its Average True Range was 53.96.
Raw Stochastic average of CytomX Therapeutics Inc (CTMX) in the period of the previous 100 days is set at 82.41%, which indicates a major rise in contrast to 63.64% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.25 that was higher than 0.23 volatility it exhibited in the past 100-days period.
